---
title: "NERV.US (NERV.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/NERV.US/news.md"
symbol: "NERV.US"
name: "NERV.US"
parent: "https://longbridge.com/zh-CN/quote/NERV.US.md"
datetime: "2026-03-12T23:02:47.146Z"
locales:
  - [en](https://longbridge.com/en/quote/NERV.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NERV.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NERV.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/NERV.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NERV.US/news.md)


# NERV.US (NERV.US) — 相关新闻

### [Minerva Neurosciences Warns of Major Dilution Risk From Preferred Stock Conversions and Warrant Exercises](https://longbridge.com/zh-CN/news/278826774.md)
*2026-03-12T06:01:01.000Z*
> Minerva Neurosciences Warns of Major Dilution Risk From Preferred Stock Conversions and Warrant Exercises

### [NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease](https://longbridge.com/zh-CN/news/278712431.md)
*2026-03-11T11:30:02.000Z*
> NeuroThera Labs Inc. has announced the publication of an international patent in collaboration with Clearmind Medicine f

### [Minerva Neurosciences 10-K: Revenue $0, EPS (34.67) on large net loss](https://longbridge.com/zh-CN/news/278718170.md)
*2026-03-11T12:05:02.000Z*
> Minerva Neurosciences reported zero revenue for the year, with a net loss of $293.42 million and a basic net loss per sh

### [Minerva Neurosciences | 8-K: FY2025 Revenue: USD 0](https://longbridge.com/zh-CN/news/278708716.md)
*2026-03-11T11:09:26.000Z*
### [Pre-market hot trades in US stocks: Minerva Neurosciences pre-market down 7.50%, market sentiment is low, and increased volatility has drawn attention](https://longbridge.com/zh-CN/news/278550186.md)
*2026-03-10T12:27:12.000Z*
> Minerva Neurosciences pre-market down 7.50%; Catheter Precision pre-market up 67.96%; MiNK Therapeutics pre-market up 58

### [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://longbridge.com/zh-CN/news/278390342.md)
*2026-03-09T12:05:42.000Z*
> In Monday's pre-market session, several health care stocks saw significant movement. Relmada Therapeutics (RLMD) surged 

### [Minerva Neurosciences (NASDAQ:NERV) Upgraded to Hold at Wall Street Zen](https://longbridge.com/zh-CN/news/277281828.md)
*2026-02-28T07:34:58.000Z*
> Wall Street Zen upgraded Minerva Neurosciences (NASDAQ:NERV) from a "sell" to a "hold" rating. Other analysts have mixed